Risk stratification biomarkers forStaphylococcus aureusbacteraemia-Reference-Cited by-同舟云学术

Risk stratification biomarkers forStaphylococcus aureusbacteraemia

Published:2020-01 Issue:2 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Cao Yi¹,Guimaraes Alessander O²,Peck Melicent C³,Mayba Oleg¹,Ruffin Felicia⁴,Hong Kyu⁵⁶,Carrasco‐Triguero Montserrat⁵,Fowler Vance G⁴,Maskarinec Stacey A⁴,Rosenberger Carrie M²^ORCID

Affiliation:

1. Bioinformatics and Computational Biology Genentech, Inc. South San Francisco CA USA

2. Biomarker Discovery Genentech, Inc. South San Francisco CA USA

3. Clinical Sciences Genentech, Inc. South San Francisco CA USA

4. Division of Infectious Diseases Duke University Durham NC USA

5. BioAnalytical Sciences Genentech, Inc. South San Francisco CA USA

6. BioAnalysis, Immune‐Onc Therapeutics Palo Alto CA USA

Funder

National Center for Advancing Translational Sciences

Genentech

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1110

Reference43 articles.

1. A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection

2. Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia

3. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research

4. Cytokine responses to Staphylococcus aureusbloodstream infection differ between patient cohorts that have different clinical courses of infection

5. Elevated Serum Interleukin-10 at Time of Hospital Admission Is Predictive of Mortality in Patients With Staphylococcus aureus Bacteremia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial;The Lancet Infectious Diseases;2024-05

2. Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates;Acta Biomaterialia;2024-01

3. The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence;Clinical Infectious Diseases;2023-12-29

4. Novel putative biomarkers for infective endocarditis by serum proteomic analysis: a comprehensive review of literature;Annals of Medicine & Surgery;2023-09-01

5. Early oral switch in low-riskStaphylococcus aureusbloodstream infection;2023-07-05